Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BCG--different strains, different vaccines?

Marcel A Behr1

  • 1McGill University Health Centre, Montreal, Canada. marcel.behr@mcgill.ca

The Lancet. Infectious Diseases
|March 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inclusion of young adolescents in policy development for new tuberculosis vaccines.

The Lancet. Global health·2026
Same author

<i>Mycobacterium avium</i>: Diversity, Clinical Significance, Old and New Targeted Medicines.

ACS infectious diseases·2026
Same author

Virulence hierarchies within the <i>Mycobacterium tuberculosis</i> complex.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials.

The Lancet. Respiratory medicine·2025
Same author

Tuberculosis.

Lancet (London, England)·2025
Same author

Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam.

The New England journal of medicine·2024
Same journal

Expert consensus on case definitions in human loiasis: a Delphi study.

The Lancet. Infectious diseases·2026
Same journal

The Bundibugyo virus disease outbreak: a warning signal for risks to health workers.

The Lancet. Infectious diseases·2026
Same journal

Trials of medical countermeasures to begin in DR Congo.

The Lancet. Infectious diseases·2026
Same journal

Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trial.

The Lancet. Infectious diseases·2026
Same journal

Context matters: WHO-recommended tools in combinations validated for community tuberculosis screening.

The Lancet. Infectious diseases·2026
Same journal

Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

The Lancet. Infectious diseases·2026
See all related articles

Bacille Calmette-Guérin (BCG) vaccines show inconsistent tuberculosis prevention. Ongoing research examines genetic differences in BCG strains to improve vaccine efficacy and safety.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbial genetics

Background:

  • Bacille Calmette-Guérin (BCG) vaccines have been used for nearly a century to prevent tuberculosis (TB).
  • Despite widespread use, their efficacy in preventing TB has been inconsistent across studies, and the underlying mechanisms remain unclear.
  • Variations among different BCG vaccine strains have been recognized since the 1940s, affecting laboratory properties.

Observation:

  • Recent genomic analyses confirm that distinct BCG strains have evolved and exhibit genetic differences compared to the original 1921 strain.
  • Some identified genetic alterations correlate with observed variations in BCG's laboratory characteristics.
  • However, the impact of these specific mutations on BCG-induced protection against TB and/or adverse effects has not yet been definitively established.

Related Experiment Videos

Findings:

  • Genomic sequencing reveals significant divergence among current BCG vaccine strains.
  • Specific genetic mutations within BCG strains are linked to altered phenotypic properties.
  • The direct correlation between these genetic changes and clinical outcomes (protection/adverse effects) requires further investigation.

Implications:

  • Understanding the genetic basis of BCG strain variation is crucial for optimizing TB prevention strategies.
  • Identifying the ideal BCG strain could enhance vaccine effectiveness and reduce variability in protection.
  • This research may pave the way for developing improved BCG vaccines with predictable efficacy and safety profiles.